F2RL3
F2RL3 (F2R like thrombin or trypsin receptor 3), also known as PAR4 or proteinase-activated receptor 4, is a G protein-coupled receptor activated by thrombin or trypsin. It signals through G proteins that stimulate phosphoinositide hydrolysis and may contribute to platelet activation. Browse Assay Genie's current range of F2RL3 research reagents below, or read on for the biology behind the target.
F2RL3 is a receptor for activated thrombin or trypsin that couples to G proteins which stimulate phosphoinositide hydrolysis. It may play a role in platelet activation. Like other members of the protease-activated receptor subfamily, it is activated by a distinctive mechanism: the receptor is proteolytically processed to reveal an extracellular N-terminal tethered ligand, which then binds to and activates the receptor itself.
The F2RL3 gene encodes a member of the protease-activated receptor subfamily, which belongs to the G protein-coupled receptor 1 family. HGNC places it in the F2R receptors gene group. The mature F2RL3 protein, often called PAR4 or proteinase-activated receptor 4, is found at the cell membrane. Mouse and rat each have an F2rl3 ortholog, so the gene can be studied in common rodent models.
According to the NCBI Gene summary, the receptor plays a role in blood coagulation, inflammation and response to pain. The same summary notes that hypomethylation at the F2RL3 gene may be associated with lung cancer in human patients. The gene has previously been named coagulation factor II (thrombin) receptor-like 3, and F2R like thrombin/trypsin receptor 3, which reflects its relationship to the thrombin receptor family. These roles make F2RL3 a relevant target for researchers studying protease signalling, haemostasis and inflammatory responses.
F2RL3 is a thrombin-activated receptor that may play a role in platelet activation, making it relevant to platelet signalling research.
The encoded receptor is linked to blood coagulation, and responds to activated thrombin through a proteolytically revealed tethered ligand.
NCBI Gene summary associates this protease-activated receptor with inflammation and response to pain, supporting work on protease-driven signalling.
Hypomethylation at the F2RL3 gene may be associated with lung cancer in human patients, a focus for methylation studies.
F2RL3 is a receptor for activated thrombin or trypsin. It couples to G proteins that stimulate phosphoinositide hydrolysis and may play a role in platelet activation. Its tethered ligand is revealed by proteolytic processing of the N-terminus, and the receptor is linked to coagulation, inflammation and pain response.
F2RL3 is also called PAR4 and proteinase-activated receptor 4. Previous HGNC names include coagulation factor II (thrombin) receptor-like 3 and F2R like thrombin/trypsin receptor 3. It sits in the F2R receptors gene group.
Mouse and rat both have an F2rl3 ortholog. In humans, NCBI Gene reports that hypomethylation at this gene may be associated with lung cancer. Check the datasheet of any product for its validated reactivity before choosing a species.
Other protease-activated receptors, thrombin pathway proteins and platelet signalling targets.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q96RI0; product specifications from Assay Genie datasheets.